IL10 and inflammatory bowel disease: Given the association of IBD patients with decreased anti-inflammatory cytokines IL-10, administration of genetically modified probiotic (beneficial microorganism) such as Lactococcus lactis to express IL-10 had demonstrated a significant remission of disease activity in CD patients during trial (Braat et al., 2006).